These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 7852547)

  • 1. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exencephaly and axial skeletal dysmorphogenesis induced by maternal exposure to cadmium in the mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1986; 6(3):245-58. PubMed ID: 3771736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogenic effects of vigabatrin in TO mouse fetuses.
    Abdulrazzaq YM; Bastaki SM; Padmanabhan R
    Teratology; 1997 Mar; 55(3):165-76. PubMed ID: 9181670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid-induced spina bifida: a mouse model.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Teratology; 1992 Feb; 45(2):145-54. PubMed ID: 1377411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations in TO mouse fetuses [corrected].
    Padmanabhan R; Ahmed I
    Reprod Toxicol; 1996; 10(5):345-63. PubMed ID: 8888407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
    Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methanol-induced neural tube defects in mice: pathogenesis during neurulation.
    Bolon B; Welsch F; Morgan KT
    Teratology; 1994 Jun; 49(6):497-517. PubMed ID: 7747271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axial skeletal and Hox expression domain alterations induced by retinoic acid, valproic acid, and bromoxynil during murine development.
    Kawanishi CY; Hartig P; Bobseine KL; Schmid J; Cardon M; Massenburg G; Chernoff N
    J Biochem Mol Toxicol; 2003; 17(6):346-56. PubMed ID: 14708090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.
    Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N
    Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate.
    Turner S; Sucheston ME; De Philip RM; Paulson RB
    Teratology; 1990 Apr; 41(4):421-42. PubMed ID: 2111044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model.
    Hill DS; Wlodarczyk BJ; Finnell RH
    Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):40-7. PubMed ID: 18186108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental phase alters dosimetry-teratogenicity relationship for 2-methoxyethanol in CD-1 mice.
    Terry KK; Elswick BA; Stedman DB; Welsch F
    Teratology; 1994 Mar; 49(3):218-27. PubMed ID: 8059429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exencephaly induction by valproic acid in the genetic polydactyly/arhinencephaly mouse, Pdn/Pdn.
    Maekawa M; Ohta K; Katagiri R; Ueta E; Naruse I
    Congenit Anom (Kyoto); 2005 Dec; 45(4):132-6. PubMed ID: 16359493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
    Sato M; Shirota M; Nagao T
    Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice.
    Harris MJ; Juriloff DM
    Teratology; 1999 Nov; 60(5):292-305. PubMed ID: 10525207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
    Padmanabhan R; Shafiullah MM
    Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE; Raymond AM; Winn LM
    Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the effect of retinoic acid on anterior neural tube closure in mice genetically liable to exencephaly.
    Tom C; Juriloff DM; Harris MJ
    Teratology; 1991 Jan; 43(1):27-40. PubMed ID: 2006470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.